Scottish CAR-T Biotech Adds Another Stellar Partner to Its Roster – Labiotech.eu (blog)
Labiotech.eu (blog) |
Scottish CAR–T Biotech Adds Another Stellar Partner to Its Roster
Labiotech.eu (blog) No financial details were disclosed, but the biotech says it validates the potential of its gamma-delta T cell-based platform to earn over the company over $1B before it reaches the market. This news comes a few months after TC Biopharm closed a deal … TC BioPharm And The NIPRO Corporation Announce Strategic Programme Co-Developing A Novel Gamma-Delta … TC BioPharm confirms cancer therapy development deal |
